User profiles for Marcela Salomao

Marcela Salomao

Mayo Clinic
Verified email at mayo.edu
Cited by 2657

Protein 4.1 R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane

M Salomao, X Zhang, Y Yang, S Lee… - Proceedings of the …, 2008 - National Acad Sciences
Protein 4.1R (4.1R) is a multifunctional component of the red cell membrane. It forms a
ternary complex with actin and spectrin, which defines the nodal junctions of the membrane-…

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH

M Salomao, MY Woojin, RS Brown Jr… - The American journal …, 2010 - journals.lww.com
In explant livers with chronic hepatitis C (HCV-C) we have noted a distinctive histologic
variant that we have termed steatohepatitic hepatocellular carcinoma (SH-HCC) with features …

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

…, KJ Kim, X Wang, A Bartolome, M Salomao… - Science translational …, 2018 - science.org
Fibrosis is the major determinant of morbidity and mortality in patients with nonalcoholic
steatohepatitis (NASH) but has no approved pharmacotherapy in part because of incomplete …

The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis

M Salomao, H Remotti, R Vaughan, AB Siegel… - Human pathology, 2012 - Elsevier
Steatohepatitis and metabolic syndrome are increasingly recognized as important risk factors
for development of hepatocellular carcinoma. We have recently described a histologic …

[HTML][HTML] Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience

TT DeLeon, MA Salomao, BA Aqel… - Journal of …, 2018 - ncbi.nlm.nih.gov
Background Patients with solid organ transplants (SOTs) have been excluded from programmed
death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitor clinical trials due …

Pembrolizumab in combination with neoadjuvant chemoradiotherapy for patients with resectable adenocarcinoma of the gastroesophageal junction

…, NR Foster, C Hartley, T Mounajjed, MA Salomao… - Clinical Cancer …, 2022 - AACR
Purpose: This phase Ib/2 trial investigated pembrolizumab-containing trimodality therapy in
patients with gastroesophageal junction (GEJ) adenocarcinoma. Patients and Methods: …

Needle-shaped ultrathin piezoelectric microsystem for guided tissue targeting via mechanical sensing

…, X Ning, R Sun, H Albadawi, M Salomao… - Nature biomedical …, 2018 - nature.com
Needles for percutaneous biopsies of tumour tissue can be guided by ultrasound or computed
tomography. However, despite best imaging practices and operator experience, high …

Silk embolic material for catheter‐directed endovascular drug delivery

J Hu, H Albadawi, Z Zhang, MA Salomao… - Advanced …, 2022 - Wiley Online Library
Embolization is a catheter‐based minimally invasive procedure that deliberately occludes
diseased blood vessels for treatment purposes. A novel silk‐based embolic material (SEM) …

Bioactive‐tissue‐derived nanocomposite hydrogel for permanent arterial embolization and enhanced vascular healing

…, I Altun, Z Zhang, H Albadawi, MA Salomao… - Advanced …, 2020 - Wiley Online Library
Transcatheter embolization is a minimally invasive procedure that uses embolic agents to
intentionally block diseased or injured blood vessels for therapeutic purposes. Embolic agents …

Histopathology of graft-vs-host disease of gastrointestinal tract and liver: an update

M Salomao, K Dorritie, MY Mapara… - American Journal of …, 2016 - academic.oup.com
Objectives: Graft-vs-host disease (GVHD) is a donor T-cell-mediated disorder affecting the
recipient’s skin, gastrointestinal tract, lungs, and liver. It complicates up to 70% of …